Notes from the Floor: Biotech Showcase, Day 2

- January 8th, 2019

The Biotech Showcase takes place in San Francisco from January 7 to 9. Here’s what happened at day two of the conference.

Tuesday (January 8) marked the second day of the Biotech Showcase in San Francisco, and the Investing News Network (INN) was again in attendance to provide investors with coverage. 

The conference, which is taking place between January 7 to January 9, and represents one of the busiest times of the year for the biotech industry, as it aligns with the JP Morgan Healthcare conference at the same time, also in San Fransisco.

Public and private companies in attendance present information to investors and experts alike at the Biotech Showcase. Panels and other meetings at the conference also provide the opportunity to hear from experts about the state of the biotech industry. Continue reading below for more on what happened on the second day of the show.

Biotech Investing: Top Stocks and Future Prospects

 
Read out 2020 biotech marketing outlook report!

On Tuesday, INN spoke with executives from Propanc Biopharma (OTCQB:PPCB), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Curis Pharma (NASDAQ:CRIS), among others.

The second day of this year’s Biotech Showcase began with numerous panels, including one called “Cell and gene therapy: The financing surge.” Pricing is always a notable concern for drugs, but panelists said pricing will likely not be as much of an issue as people continue to realize the extent of positive clinical trial data.

More company presentations took place during the day, which shared important events with investors.

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

As for the lunchtime plenary, Tuesday brought the “The financing frenzy: Is it truly the best of times?” Numerous panelists discussed how companies deal with financing, what is the best time to prepare for an initial public offering (IPO) and where is best to list, among other topics.

The audience was full of investors, management teams and media learning about how these topics will shape the coming year in regards to financing.

Investors can follow @INN_LifeScience for more updates on the conference for the final day on Wednesday (January 8). For those interested on what happened during the first day of the show, click here.

Don’t forget to follow us @INN_LifeScience for real-time updates!

Securities Disclosure: I, Gabrielle Lakusta, hold no direct investment interest in any company mentioned in this article.

Biotech Investing: Top Stocks and Future Prospects

 
Read out 2020 biotech marketing outlook report!

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply